Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

INDGN - Fundamental Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Fundamental List

Fundamental Rating: 4.2

πŸ“Š Core Financials Analysis

Profitability

ROE of 20.6% and ROCE of 24.8% reflect strong capital efficiency.

EPS of β‚Ή17.0 and quarterly PAT growth of 26.3% show solid earnings momentum.

Low debt-to-equity ratio of 0.04 indicates a healthy balance sheet with minimal leverage risk.

Cash Flow & Dividend

Dividend yield of 0.36% is modest, but sustainable given profitability.

Likely strong operating cash flows, though not explicitly stated.

πŸ“‰ Valuation Indicators

Metric Value Interpretation

P/E Ratio 31.7 Reasonable vs. industry PE of 50.6 β€” undervalued

P/B Ratio ~5.03 Slightly high, but justified by strong ROE

PEG Ratio 1.06 Fairly valued relative to growth

Intrinsic Value Likely close to current price β€” not deeply undervalued, but not overpriced either

🏒 Business Model & Competitive Advantage

Sector: Specialty chemicals β€” high-margin, innovation-driven, and export-oriented.

Moat

Strong R&D, niche product portfolio, and global customer base.

Low debt and high return metrics offer resilience and scalability.

Ownership Trends

FII holding surged (+4.80%) and DII also increased (+2.24%) β€” strong institutional confidence.

πŸ“‰ Technical & Sentiment Indicators

RSI at 38.4 β€” nearing oversold zone.

MACD negative and price below both 50-DMA and 200-DMA β€” bearish trend.

Volume below average β€” possible accumulation phase.

🎯 Entry Zone & Long-Term Guidance

Suggested Entry Zone: β‚Ή510–₹540 range (near RSI support and below DMA levels)

Long-Term View

Attractive for long-term investors seeking exposure to high-growth specialty chemicals.

Strong fundamentals, low debt, and institutional backing make it a solid compounder.

Hold for 3–5 years with periodic review of product pipeline and export performance.

Would you like a peer comparison with companies like Navin Fluorine or Alkyl Amines to assess relative valuation and growth potential?

Edit in a page

Back to Fundamental List